University of Texas/Texas AM Investment Management Co (UTIMCO)’s AbbVie ABBV Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Buy	+1,204	New	+$259K	0.04%	135
2026 Q1	–	Sell	-160	Closed	-$36.6K	–	302
2025 Q4	$36.6K	Buy	+160	New	+$36.4K	0.01%	213
2025 Q2	–	Sell	-12	Closed	-$2.51K	–	162
2025 Q1	$2.51K	Sell	12 -702	-98%	-$136K	﹤0.01%	155
2024 Q4	$127K	Hold	714	–	–	0.02%	112
2024 Q3	$141K	Hold	714	–	–	0.02%	101
2024 Q2	$122K	Sell	714 -250	-26%	-$41.4K	0.02%	112
2024 Q1	$176K	Buy	964 +250	+35%	+$43.1K	0.04%	92
2023 Q4	$111K	Hold	714	–	–	0.03%	85
2023 Q3	$106K	Buy	+714	New	+$105K	0.04%	36
2023 Q1	–	Sell	-1,500	Closed	-$242K	–	21
2022 Q4	$242K	Buy	+1,500	New	+$230K	0.09%	18
2019 Q1	–	Sell	-1,096	Closed	-$101K	–	43
2018 Q4	$101K	Buy	1,096 +833	+317%	+$73.3K	0.11%	32
2018 Q3	$25K	Buy	+263	New	+$24.9K	0.03%	16
2018 Q1	–	Sell	-345	Closed	-$33K	–	16
2017 Q4	$33K	Buy	+345	New	+$32.5K	0.13%	29
2014 Q3	–	Sell	-400	Closed	-$23K	–	24
2014 Q2	$23K	Buy	+400	New	+$21K	0.01%	36

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s ABBV Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in AbbVie (ABBV) in Q2 2026: 1,204 shares worth $303K. The stake represents 0.04% of the portfolio and ranks #135 among its holdings. This is a return to the name: University of Texas/Texas AM Investment Management Co (UTIMCO) previously reported a position in ABBV as recently as Q4 2025.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in ABBV in Q2 2014 and has held it in 14 quarters since. 3,454 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

University of Texas/Texas AM Investment Management Co (UTIMCO) held 1,204 shares of AbbVie worth $303K as of Q2 2026.
AbbVie was a new University of Texas/Texas AM Investment Management Co (UTIMCO) position in Q2 2026.
AbbVie made up 0.04% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #135 holding.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in AbbVie in Q2 2014 and has held it in 14 quarters since.
3,454 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.